Moods Disorders Completed Phase 2 Trials for Buspirone (DB00490)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00149617Effectiveness of Buspirone and Motivational Enhancement Therapy for the Treatment of Marijuana Dependence - 1Treatment